<?xml version="1.0" encoding="UTF-8"?>
<div class="fig" id="PMC4542094/figure_5" xmlns="http://www.w3.org/1999/xhtml">
 <caption> Isobologram showing the in vitro interaction between amantadine and doxorubicin, cisplatin or 5FU in HCT8 WT and HCT8 RETO cells. Dose-response curves are based on the respective IC 50 values calculated after 24 hours of incubation. Amantadine-doxorubicin are synergistic in HCT8 WT/RETO ( a &amp; b). Amantadine-cisplatin are additive in HCT8 wildtype ( c) and synergistic in HCT8 RETO ( d). Amantadine-5FU are synergistic in RETO ( f) but antagonistic in HCT8 WT ( e). n = 3 independent experiments </caption>
 <div class="graphic"/>
 <p class="label">Fig. 5</p>
</div>
